Hemorrhage clinical trials at University of California Health
4 in progress, 0 open to eligible people
Empiric Calcium in Massive Transfusion
Sorry, not yet accepting patients
Calcium helps blood to clot and thereby stop bleeding. Trauma patients who experience large volume blood loss often require blood transfusions and bleeding is the most common cause of death. The purpose of this study is to see if giving intravenous…
at UC Irvine
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
Sorry, not yet accepting patients
Although procedural abortion in the second trimester is extremely safe, hemorrhage is one of the leading causes of morbidity and mortality. Tranexamic acid (TXA) is used commonly in obstetrics to prevent or manage intrapartum or postpartum…
at UCSD
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: an Efficacy Study
Sorry, not yet accepting patients
Trauma is the leading cause of death and disability in children in the United States. The objective of this study is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children with…
at UC Davis
Obsidio™ Conformable Embolic Registry
Sorry, not currently recruiting here
OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects …
at UCLA
Our lead scientists for Hemorrhage research studies include Daniel K Nishijima, MD, MAS Zachary Haber, MD Nathan Kuppermann, MD, MPH Jeffry Nahmias, MD.
Last updated: